While migraines are common, especially among women, treating them in the elderly is often a challenged due to various health risks such as cardiovascular disease events.
Finally, researchers have found a safe and effective solution for relieving migraines in elderly women: Hormone therapy, a medical treatment used to reduce symptoms of menopause.
Study finds that hormone therapy is a safe and effective way to treat migraines in elderly women
To reach these findings, the researchers behind the study looked at data from the Women’s Health Initiative (WHI) that demonstrates the safety of hormone therapy for the American population. They analysed data for the 67,903 participants of the WHI clinical trials to further examine the relationship between migraines and cardiovascular disease events, and their interaction with hormone therapy use.
The researchers found that women with migraines tended to exercise
and drink less than those without migraines and had higher vitamin D and calcium intake. Migraine sufferers were also more likely to have symptoms of hot flashes and night sweats. However, the researchers didn’t find a relationship between cardiovascular disease risk and a history of migraines. More importantly, they found that hormone therapy didn’t affect this relationship from a safety perspective.
The researchers presented the full findings of their study at The North American Menopause Society (NAMS) Annual Meeting in Philadelphia in the United States in October.
Does your memory let you down at the most awkward of times?
Do you find yourself saying…
It’s awfully embarrassing, isn’t it? Put an end to these memory misfires once and for all, here’s how…
What’s that place called again?
Have you seen that? Um…um… It’s on the tip of my tongue…
Or, what’s his name again?
Hormone therapy has been on the decline due to safety concerns…
“Hormone therapy use has been on the decline since the WHI clinical trials. Newer data has brought further clarity to its safe use, especially in younger women (below 60) who are closer to the time of menopause (within 10 years of menopause),” said Dr Peter F Schnatz, one of the study’s authors and immediate past president of NAMS.
“Based on this newer data, hormones still have a major role in treating menopause symptoms and preventing bone loss. A number of these women will have migraines. Hence, knowing the risk/benefit profile of hormone therapy in these women is critically important,” added Dr Schnatz.
For more information on hormone therapy for treating migraines, consult your doctor.
Note: 5 of 1 vote